The purpose of the study is to identify lifestyle factors associated with PCOS and understand how diet and activity levels impact features of PCOS. The secondary aim is to examine psychosocial factors (e.g., health beliefs) of women with PCOS.
Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects 6-12% of reproductive-aged women within the general population. Currently, there is limited knowledge on the current lifestyles of women with PCOS and the psychosocial factors associated with PCOS. The researchers plan to examine potential lifestyle differences and psychosocial factors between PCOS and healthy women. The Research Team is also interested in the relationships between biological markers and lifestyle endpoints in women with and without PCOS. Previous literature has shown there are biological marker differences between those with and without PCOS. By examining these relationships, researchers may further understand whether PCOS status is associated with lifestyle parameters. To accomplish these objectives, 360 women (120 women with PCOS, 120 women without PCOS and with normal menstrual cycles, and 120 women without PCOS and with irregular menstrual cycles) will be included in this study. An equal number of lean and overweight/obese women will be recruited within each group based on body mass index (BMI; Lean = 18 - 24 kg/m2 and overweight/obese ≥ 25 kg/m2). Women will be included in the PCOS group if they have a confirmed PCOS diagnosis from their primary care provider. Participants will complete a food frequency questionnaire, a sleep questionnaire, and a physical activity questionnaire. A researcher may also provide participants with a waist-worn accelerometer to monitor physical activity and a wrist-worn accelerometer to monitor sleep for a week. Ultrasound scans of the ovaries will be assessed and the following metabolic parameters will be assessed: (1) 75-gram oral glucose tolerance test; (2) dual X-ray absorptiometry (DXA) scan; (3) vitals and anthropometry assessment to measure waist and hip circumference, height, weight, blood pressure, and heart rate; (4) fasting blood tests to detect androgens (i.e., total testosterone, androstenedione, free androgen index); and (5) an (optional) subcutaneous fat biopsy. Women with and without PCOS will also be asked to complete a questionnaire that will assess the psychosocial factors (e.g., health beliefs). This can be conducted online, in person, or through phone.
Study Type
OBSERVATIONAL
Enrollment
126
Human Metabolic Research Unit, Cornell University
Ithaca, New York, United States
Strong Fertility Center
Rochester, New York, United States
CRC at University of Rochester Medical Center
Rochester, New York, United States
Differences in diet between women with and without PCOS
A food frequency questionnaire will be administered to assess diet composition for the last three months.
Time frame: 1 week
Differences in exercise between women with and without PCOS
An accelerometer will be administered to assess physical activity for 1 week.
Time frame: 1 week
Differences in psychosocial factors (e.g., health beliefs) of women with and without PCOS
A questionnaire will be administered to assess psychosocial factors of women with PCOS.
Time frame: 1-2 weeks
Differences in sleep patterns between women with and without PCOS
A wrist-worn accelerometer will be administered to assess sleep patterns for 6 consecutive nights.
Time frame: 6 consecutive nights
LH-FSH ratio
The ratio of circulating LH to FSH concentrations in the serum will be determined for each participant and compared across groups
Time frame: 1 day
Hirsutism Score
Degree of hirsutism as judged by the Ferriman-Gallwey scale will be determined and compared across groups Degree of hirsutism as judged by the Ferriman-Gallwey scale will be determined and compared across groups
Time frame: 1 day
Androgen concentrations
Total testosterone, androstenedione and free androgen index concentrations in serum will be determined and compared across groups.
Time frame: 1 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Menstrual Cycle Length
Average menstrual cycle length as determined by self-reported history will be determined and compared across groups
Time frame: 1 day
Body Mass Index
The ratio of weight to height will be determined and compared across groups.
Time frame: 1 day
Waist-to-Hip Ratio
The ratio of waist circumference to hip circumference will be determined and compared across groups
Time frame: 1 day
Ovarian Volume
The size of each ovary will be determined using ultrasonography for each participant during study participation and compared between groups.
Time frame: 1 day
Insulin Sensitivity
Insulin sensitivity will be determined by administration of an oral glucose tolerance test and compared between groups.
Time frame: 1 day
Serum progesterone concentration
The serum progesterone concentration will be determined during study participation, assessed in association with luteal dynamics and compared between groups.
Time frame: 1 day
Blood pressure
Blood pressure will be determined and compared between groups.
Time frame: 1 day
Serum markers of metabolic syndrome
Lipids, glucose and HbA1C concentrations will be determined and compared between groups.
Time frame: 1 day
Body fat distribution
Percentage and distribution of fat and lean mass as assessed using DXA technology will be compared between groups.
Time frame: 1 day
Subcutaneous fat biopsy (optional)
Subcutaneous fat cells, which represent important sites of reproductive hormone synthesis, will be assessed and compared across groups
Time frame: 1 day